胆道癌症,版本2.2025,NCCN瘤学临床实践指南
Al B Benson1, Michael I D'Angelica2, Thomas Abrams3
11Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Journal of the National Comprehensive Cancer Network : JNCCN
|September 10, 2025
概括
该指南为胆道癌 (BTC) 提供专家建议,重点是辅助化疗,化学辐射和高级阶段的全身治疗. 这些指导方针确保了对胆囊,肝内和肝外胆管癌患者的综合护理.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 临床实践指南 临床实践指南
背景情况:
- 胆道癌 (BTCs),包括胆囊癌,肝内癌和肝外胆道癌,需要标准化的管理策略.
- 国家综合癌症网络 (NCCN) 召集多学科专家小组,制定基于证据的指导方针.
- 定期更新确保指南反映了最新的诊断和治疗数据.
研究的目的:
- 提出NCCN指导方针,用于对胆道癌患者的综合护理.
- 详细说明可切除BTC的辅助化疗和化疗辐射的建议.
- 为患有晚期或转移性BTC的患者概述全身治疗选择.
主要方法:
- 该指南是通过一个涉及多学科的瘤专家小组的共识过程来制定的.
- 该小组每年审查新研究,临床试验数据和治疗结果.
- 建议是基于最好的现有科学证据和专家临床判断.
主要成果:
- 该指南为BTC的评估和多学科管理提供了具体建议.
- 辅助化疗和化疗辐射的策略概述了可切除疾病.
- 系统疗法选择,包括向疗法和免疫疗法,讨论了高级BTCs.
结论:
- "NCCN指南"为患有胆道癌症的患者提供了最佳的,基于证据的护理框架.
- 遵守这些准则可以通过标准化和综合治疗方法改善患者的治疗结果.
- 对新兴疗法的持续评估对于推进BTC管理至关重要.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:


